Antiviral drugs against SARS-CoV-2

The use of antiviral drugs represents an important progress in the therapeutic management of COVID-19, leading to a substantial reduction of SARS-CoV-2-related complications and mortality. In immunocompetent host, peak viral replication occurs around the symptom’s onset, and it prolongs for 5 to 7 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiello, Tommaso Francesco, García-Vidal, Carolina, Soriano, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2022
Materias:
Approach to management of SARS-CoV-2 infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717461/
https://www.ncbi.nlm.nih.gov/pubmed/36285850
http://dx.doi.org/10.37201/req/s03.03.2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717461/
https://www.ncbi.nlm.nih.gov/pubmed/36285850
http://dx.doi.org/10.37201/req/s03.03.2022

Ejemplares similares